Sales : +91-777 804 8217
| Sr No | Corrigendum Date | Corrigendum | Type | New Submission Date |
|---|---|---|---|---|
| 1 | 10-01-2024 | 18-01-2024 | ||
| 2 | 28-12-2023 | 11-01-2024 |
| Sl. No. | Item Title | |
| 1 | NIPT | |
| 2 | 1 25 Dihydroxy Vitamin D | |
| 3 | 13, 18, 21 FISH Panel | |
| 4 | 13, 18, 21, X, Y FISH Panel | |
| 5 | 17-OH (Hydroxy) Progesterone | |
| 6 | 18s Sequencing & Analysis on Illumina Platforms (Sample-1) | |
| 7 | 1p/19q deletion | |
| 8 | 20q deletion | |
| 9 | 24 Hour Total Porphyrins in Urine | |
| 10 | 24 Hour Urine 17 Ketosteroids | |
| 11 | 24 Hour Urine 5-Hiaa | |
| 12 | 24 HOUR URINE ALBUMIN | |
| 13 | 24 Hour Urine Calcium | |
| 14 | 24 HOUR URINE CATECHOLAMINES | |
| 15 | 24 Hour Urine Chloride (Cl-) | |
| 16 | 24 HOUR URINE CITRATE | |
| 17 | 24 Hour Urine Copper | |
| 18 | 24 Hour Urine Cortisol | |
| 19 | 24 Hour Urine Creatinine | |
| 20 | 24 Hour Urine creatinine clearance test | |
| 21 | 24 Hour Urine Magnesium | |
| 22 | 24 Hour Urine Metanephrine | |
| 23 | 24 Hour Urine Microalbumin | |
| 24 | 24 Hour Urine Oxalate | |
| 25 | 24 Hour Urine Phosphorus | |
| 26 | 24 HOUR URINE PORPHOBILINOGEN | |
| 27 | 24 Hour Urine Potassium(K+) | |
| 28 | 24 Hour Urine Protein | |
| 29 | 24 Hour Urine Sodium (Na+) | |
| 30 | 24 HOUR URINE UREA | |
| 31 | 24 HOUR URINE UREA NITROGEN | |
| 32 | 24 Hour Urine Uric Acid | |
| 33 | 24 Hour Urine VMA | |
| 34 | 24 Hours Diagnostic Panel (Metabolic Study) | |
| 35 | 24 HOURS URINE FOR PROTEIN ELECTROPHORESIS | |
| 36 | 24 HOURS URINE METABOLIC STONE SCREEN TEST | |
| 37 | 24 hours urine ZINC | |
| 38 | 3-Methylcrotonyl-CoA Carboxylase Panel - MCCC1, MCCC2 | |
| 39 | 47, XYY syndrome | |
| 40 | 5-HIAA Urine | |
| 41 | 5q deletion | |
| 42 | 7q deletion | |
| 43 | ABCD1 gene test | |
| 44 | ABPA PANEL | |
| 45 | ACE (Angiotensin Converting Enzyme) Level | |
| 46 | ACE LEVEL CSF | |
| 47 | Acetone | |
| 48 | Acetylcholine Receptor Antibody (ACHR) | |
| 49 | Achondroplasia (Targeted) - FGFR3 | |
| 50 | ACID PHOSPHATASE | |
| 51 | ACTH Edta Plasma | |
| 52 | Activated Protein C Resistance (APCR) | |
| 53 | ACTIVE B12 LEVEL | |
| 54 | ACUTE LEUKEMIA REFLEX PANEL | |
| 55 | Adenosine Deaminase (ADA) | |
| 56 | ADH-Anti Diuretic Hormone | |
| 57 | Adrenaline (Epinephrine) Plasma | |
| 58 | Adrenocorticotropic Hormone (ACTH) | |
| 59 | Adrenoleukodystrophy (ALD) | |
| 60 | AFB Blood Culture By Bact/Alert 3d | |
| 61 | AFB Bone Marrow Culture By Bact/Alert 3d | |
| 62 | AFB By Fluorescent Stain | |
| 63 | AFB Culture By Bactalert/Bactec (MGIT) Method | |
| 64 | AFB culture by conventional method | |
| 65 | AFB Fluid | |
| 66 | AFB FOR THREE DAYS | |
| 67 | AFB SENSITIVITY - SINGLE DRUG BY BACTEC MGIT | |
| 68 | AFB sensitivity 13 drugs | |
| 69 | AFB SENSITIVITY 1ST LINE DRUGS SIREP BY BACTEC | |
| 70 | AFB SENSITIVITY 1ST LINE DRUGS SIREP | |
| 71 | AFB SENSITIVITY 2ND LINE DRUGS BY BACTEC | |
| 72 | AFB SENSITIVITY 2ND LINE DRUGS | |
| 73 | AFB Sensitivity By Conventional Method (Single Drug) | |
| 74 | AFB SENSITIVITY FOR MOTT | |
| 75 | AFB Sensitivity10 (1st And 2nd Line) Drug Sensitivity By Bactalert/Bactec MGIT | |
| 76 | AFB SENSITIVITY10 (1ST AND 2ND LINE) DRUG SENSITIVITY BY BACTEC MGIT | |
| 77 | AFB-MTB Antibiogram-Add Drugs-4Nos. MACC | |
| 78 | AFP Fluid | |
| 79 | AFP - MOM | |
| 80 | AFP (Alpha Feto Protein) | |
| 81 | Agammaglobulinemia, X-linked 1 (XLA) | |
| 82 | Alagille syndrome 1 (ALGS1 ) | |
| 83 | Alagille Syndrome Panel - JAG1, NOTCH2 | |
| 84 | Albert Stain | |
| 85 | Albumin | |
| 86 | Albumin Creatinine Ratio Urine | |
| 87 | Albumin Fluid | |
| 88 | Alcohol Level | |
| 89 | Aldolase | |
| 90 | Aldosterone Level | |
| 91 | Aldosterone/Renin Activity Ratio | |
| 92 | ALK 1 (IHC Marker) | |
| 93 | ALK-1 Mutation | |
| 94 | Alkaline Phosphatase | |
| 95 | ALKAPTONURIA URINE QUALITATIVE | |
| 96 | ALL Comprehensive Panel 1 | |
| 97 | ALL FISH and Karyotyping Panel | |
| 98 | ALL FISH Panel | |
| 99 | ALL Multiplex Panel - 6 Fusions [T(9;22) T(12;21) T(1;19) T(4;11) T(9;11) T(11;19) | |
| 100 | ALL MULTIPLEX PANEL (t(9;22) t(12;21) t(1;19) t(4;11) | |
| 101 | ALL PANEL C - KARYOTYPING FISH MLL PCR t(12;21) PCR t(9;22) PCR t(1;19) | |
| 102 | ALL PANEL A- FISH t(12;21) FISH t(9;22) FISH MLL GENE REARRANGEMENT FISH t(1;19) | |
| 103 | ALL PANEL B- FISH TEL-AML t(12;21) FISH BCR-ABL t(9;22) FISH MLL t(1;19) | |
| 104 | ALL POSITIVE PANEL | |
| 105 | Allergen-Amoxicillin (Antibiotic) | |
| 106 | Allergen-Ampicillin (Antibiotic) | |
| 107 | Allergen-Cephalosporin (Antibiotic) | |
| 108 | Allergen-Penicilloyl G (Antibiotic) | |
| 109 | Allergen-Penicilloyl V (Antibiotic) | |
| 110 | Allergen-Sulpha (Antibiotic) | |
| 111 | Allergy - Microarray (300 Allergens ) | |
| 112 | Allergy Milk | |
| 113 | ALLERGY TEST - DRUGS | |
| 114 | ALLERGY TEST - FOOD NONVEG | |
| 115 | ALLERGY TEST - FOOD VEG | |
| 116 | ALLERGY TEST - POLLENS + CONTACTS | |
| 117 | ALLERGY TEST - VEG + POLLENS + CONTACTS | |
| 118 | ALLERGY TEST - VEG + POLLENS + CONTACTS + DRUGS | |
| 119 | ALLERGY TEST - VEG + POLLENS + CONTACTS + DRUGS + NONVEG | |
| 120 | ALLERGY TEST - VEG + POLLENS + CONTACTS + NONVEG | |
| 121 | Allergy Test - Inhalant | |
| 122 | Alpha Thalassemia deletion/ duplication analysis by MLPA | |
| 123 | Alpha Thalassemia X-linked Intellectual Disability Test - ATRX | |
| 124 | Alpha thalassemia/mental retardation syndrome | |
| 125 | Alpha-1 Antitrypsin | |
| 126 | Alport syndrome, X-linked (ATS) | |
| 127 | ALTERNARIA ALTERNATE - SPECIFIC IGG | |
| 128 | Alternating hemiplegia of childhood panel (upto 5 genes) | |
| 129 | Aluminium Level Fluid | |
| 130 | Aluminium Level Serum | |
| 131 | Alzheimer disease 1, familial (AD1) | |
| 132 | Amebiasis ( Entamoeba Histolytica) Antibodies-IgG | |
| 133 | Amino Acid Quantitative Plasma | |
| 134 | Amino Acid Urine | |
| 135 | AML Comprehensive Panel 1 | |
| 136 | AML FISH and Karyotyping Panel | |
| 137 | AML FISH Panel | |
| 138 | AML GENE PANEL - BASIC (FLT3 NPM1 CEBPA) | |
| 139 | AML MULTIPLEX ADVANCE (BCR-ABL PML-RARA AML-ETO Inv 16 NPM1 FLT3 CEBPA) | |
| 140 | AML NEO PANEL -FISH t(8;21) FISH Inv(16) PCR NPM-1/CEBPA/ FLT -3 MUTATION | |
| 141 | AML PANEL- KARYOTYPING FISH MLL FISH t(8;21) FISH t(15;17) FISH inv(16) | |
| 142 | AML PANEL- FISH MLL FISH t(8;21) FISH t(15;17) FISH inv(16) | |
| 143 | AML PANEL -(PCR NPM1 FLT3 DNMT3A CEBPA IDH 1&2) | |
| 144 | AML POSITIVE PANEL | |
| 145 | AML PROGNOSTIC PANEL (AML-ETO/INV.-16/PML-RARA/FLT-3) | |
| 146 | Ammonia | |
| 147 | Amoebiasis Antibody-IgG | |
| 148 | AMYLASE | |
| 149 | Amylase - Body Fluid | |
| 150 | Amylase Urine | |
| 151 | Amyotrophic lateral sclerosis panel (upto 19 genes) | |
| 152 | ANA (ELISA) | |
| 153 | ANA (IFA) | |
| 154 | ANA By CLIA | |
| 155 | ANA Profile (BLOT) 25 Parameters | |
| 156 | ANCA (IFA) | |
| 157 | ANCA-C (Pr3) | |
| 158 | ANCA-P (Mpo) | |
| 159 | Anderson-Tawil Syndrome - KCNJ2 | |
| 160 | Androgen Insensitivity Panel - AR, SRD5A2, NR0B1, NR5A1, SRY | |
| 161 | Androgen insensitivity syndrome (AIS) | |
| 162 | Androstenedione | |
| 163 | ANEUPLOIDY BY QF-PCR (WITH MCC) | |
| 164 | Angelman syndrome (AS ) | |
| 165 | Anion Gap | |
| 166 | Aniridia (AN) | |
| 167 | Aniridia Test - PAX6 | |
| 168 | Anti - HBs | |
| 169 | Anti Cardiolipin Antibody (IgG & IgM) | |
| 170 | Anti Cardiolipin Antibody IgA | |
| 171 | Anti Cardiolipin Antibody IgG | |
| 172 | Anti Cardiolipin Antibody IgM | |
| 173 | Anti CCP | |
| 174 | ANTI COMPLEMENT FACTOR H | |
| 175 | Anti D Titre | |
| 176 | Anti DNAse | |
| 177 | ANTI DNAse B | |
| 178 | Anti Ds DNA (By IFA) | |
| 179 | Anti Ds DNA (ELISA) | |
| 180 | Anti GAD Antibodies (for Type I diabetes) | |
| 181 | Anti Gad65 Test Clia | |
| 182 | Anti GBM Antibody (Glomerular Basement Membrane) | |
| 183 | Anti HAV IgG | |
| 184 | Anti HAV IgM | |
| 185 | Anti HAV Total | |
| 186 | Anti HBC IgM | |
| 187 | Anti HBcAb IgM | |
| 188 | Anti HBcAb Total | |
| 189 | Anti HBe Antibodies | |
| 190 | Anti HBs | |
| 191 | ANTI HCV By eCLIA/CMIA | |
| 192 | ANTI HCV BY ELISA | |
| 193 | Anti HCV IgM | |
| 194 | Anti HEV IgG | |
| 195 | Anti HEV IgM | |
| 196 | Anti Insulin Antibody | |
| 197 | Anti ISLET Cell Antibodies | |
| 198 | Anti Mag Ab | |
| 199 | Anti Mitochondrial Antibody (AMA) By Elisa | |
| 200 | Anti Mitochondrial Antibody By IFA | |
| 201 | Anti Mullerian Hormone (AMH) | |
| 202 | Anti Musk Antibody | |
| 203 | Anti NMO Antibody, CSF | |
| 204 | ANTI NMO Antibody, Serum | |
| 205 | Anti Parietal Cell Antibody | |
| 206 | Anti Phospholipid Antibody IgA | |
| 207 | Anti Phospholipid Antibody IgG | |
| 208 | Anti Phospholipid Antibody IgM | |
| 209 | Anti Phospholipid IgG & IgM | |
| 210 | Anti Phospholitic Syndrom Panel | |
| 211 | Anti Platelet Factor4(PF4) Antibody | |
| 212 | Anti Smooth Muscle Antibody (ASMA) | |
| 213 | Anti Sperm Ab Serum | |
| 214 | ANTI SYNTHETASE ANTIBODY PROFILE | |
| 215 | Anti TG (Anti Thyroglobulin) Antibody | |
| 216 | Anti Thrombin III | |
| 217 | Anti Thyroglobulin Antibody (Atg) | |
| 218 | Anti Thyroid Antibody (Anti Thyroglobulin Antibody & Anti TPO) | |
| 219 | Anti TPO (Anti Microsomal) Antibody | |
| 220 | ANTI TREPONEMAL ANTIBODY | |
| 221 | Anti Tubercular 3drugs panel By HPLC | |
| 222 | ANTI VgKC; CSF | |
| 223 | ANTI VgKC; Serum | |
| 224 | Anti-centromere(CENP) | |
| 225 | ANTIFUNGAL SENSITIVITY | |
| 226 | ANTIHISTONE | |
| 227 | Antistreptolysin-O (ASO) | |
| 228 | Antithrombin III Deficiency Test SERPINC1 | |
| 229 | Aortopathy Comprehensive Panel - 22 genes | |
| 230 | APC gene mutation analysis on blocks | |
| 231 | Apolipoprotein A1 | |
| 232 | Apolipoprotein B | |
| 233 | Apolipoprotein (A1 & B) | |
| 234 | APTT | |
| 235 | Aquaporin-4 Antibodies (Nmo-IgG) CSF | |
| 236 | Aquaporin-4 Antibodies (Nmo-IgG) Serum | |
| 237 | Arsenic Level | |
| 238 | ARSENIC LEVEL IN LIVER BIOPSY | |
| 239 | ARSE-Related Chondrodysplasia Punctata Test - ARSE | |
| 240 | Arterial Blood Gas Analysis (ABG) | |
| 241 | ASCA IgA | |
| 242 | ASCA IgG | |
| 243 | Ascitic Fluid Analysis | |
| 244 | ASMA BY IFA | |
| 245 | Asperger syndrome,X-linked, susceptibility to, 1 (ASPGX1) | |
| 246 | Aspergillosis IgG | |
| 247 | Aspergillosis IgM | |
| 248 | Aspergillus (Galactomannan Ag) Serum | |
| 249 | Aspergillus (Galactomannan Ag) Bal | |
| 250 | Aspergillus Specific IgE | |
| 251 | ASPERGILLUS. FUMIGATUS - SPECIFIC IGG | |
| 252 | Asphyxiating Thoracic Dystrophy Panel - DYNC2H1, IFT80, TTC21B | |
| 253 | Ataxia-Telangiectasia Test - ATM | |
| 254 | á-athalassemia (additional variants) (single) | |
| 255 | á-thalassemia (Targeted) - 17 genetic variants; with maternal cell contamination analysis | |
| 256 | á-thalassemia (Targeted) - 17 genetic variants | |
| 257 | ATP7A-Related Disorders | |
| 258 | Atypical Mycobacteria Species Identification | |
| 259 | Autism Panel | |
| 260 | Auto Hemolysis Test | |
| 261 | Autoimmune encephalitis Panel CSF | |
| 262 | Autoimmune encephalitis Panel Serum | |
| 263 | AUTOIMMUNE HEPATIC PROFILE | |
| 264 | Automated Semen Analysis | |
| 265 | Autophagic Vacuolar Myopathy panel (3 genes) | |
| 266 | AVIDITY TEST RUB IGG | |
| 267 | AVIDITY TEST TOXO IGG | |
| 268 | AVIDITY TEST CMV IGG | |
| 269 | Axenfeld-Rieger Panel - FOXC1, PITX2, PAX6 | |
| 270 | Axenfeld-Rieger Syndrome Panel | |
| 271 | BAL (Broncho Alveolar Lavage) Analysis | |
| 272 | BAL FOR CD4/CD8 RATIO | |
| 273 | Bannayan-Riley-Ruvalcaba syndrome (BRRS) | |
| 274 | BAP1 Hereditary Cancer Predisposition Syndrome Test - BAP1 | |
| 275 | Baraitser-Winter Cerebrofrontofacial Syndrome panel | |
| 276 | Bardet-Biedl Syndrome Panel- 15 genes | |
| 277 | Barth Syndrome - TAZ | |
| 278 | Bartter syndrome, antenatal, type 2 | |
| 279 | Basal cell nevus syndrome (BCNS) | |
| 280 | Basal Cell Nevus Syndrome Panel-PTCH1, SUFU, PTCH2 | |
| 281 | Basal Ganglion Antibody | |
| 282 | BCR-ABL Qualitative by real- time PCR | |
| 283 | BCR-ABL Quantification (Major and Minor) by real-time PCR | |
| 284 | BCR-ABL Quantification (Major) by real-time PCR | |
| 285 | BCR-ABL Quantification (Minor) by real-time PCR | |
| 286 | Beckwith-Wiedemann syndrome (BWS) | |
| 287 | Bence Jones Protein | |
| 288 | Benzodiazapine | |
| 289 | Beta 2 Glycoprotein IgG & IgM | |
| 290 | Beta 2 Glycoprotein IgA | |
| 291 | Beta 2 Glycoprotein IgG | |
| 292 | Beta 2 Glycoprotein IgG IgM & IgA | |
| 293 | Beta 2 Glycoprotein IgM | |
| 294 | Beta 2 Microglobulin | |
| 295 | Beta 2 Microglobulin-Urine | |
| 296 | Beta Carotene Level | |
| 297 | Beta Crosslaps | |
| 298 | Beta D Glucan Level Fungitell | |
| 299 | Beta Glucosidase Enzyme Assay | |
| 300 | Beta HCG | |
| 301 | Beta Thalassemia deletion/ duplication analysis by MLPA | |
| 302 | BETA-HCG Fluid | |
| 303 | Beta-Trace Protein(BTP) CSF Leakage In Body Fluid | |
| 304 | BETHESDA ASSAY (Quantitative factor Inhibitor) | |
| 305 | Bicarbonate (HCO3) | |
| 306 | Bile Acid | |
| 307 | Bilirubin | |
| 308 | Biofire by multiplex PCR | |
| 309 | BIOFIRE CSF PANEL | |
| 310 | Biofire Gastro Intestinal (GI)Panel | |
| 311 | Biofire Pneumonia Plus Panel | |
| 312 | Biofire Respiratory Panel | |
| 313 | Biopsy Endomyocardial (post Transplant) with C4d and CD68 | |
| 314 | Biopsy Large ( > 10 Blocks) | |
| 315 | Biopsy Medium (4-10 Blocks) | |
| 316 | Biopsy Small ( 1-3 Blocks) | |
| 317 | BIOTINDASE ACTIVITY | |
| 318 | Biotinidase Deficiency Test - BTD (targeted) | |
| 319 | Birt-Hogg Dube Syndrome - FLCN | |
| 320 | BKV Qualitative PCR | |
| 321 | Bleeding Time | |
| 322 | Blepharophimosis, ptosis, and epicanthus inversus (BPES) | |
| 323 | Blood Gas Analysis | |
| 324 | Blood Gas Analysis With Electrolyte | |
| 325 | Blood Gas With Lectate | |
| 326 | Blood Group | |
| 327 | Bloom Syndrome - BLM | |
| 328 | BM ASPIRATION FOR STEM CELL COLLECTION | |
| 329 | BM Iron Stain | |
| 330 | BNP(B-Type Natriuretic Peptide) | |
| 331 | Bone Marrow (BM) Biopsy | |
| 332 | Bone Marrow (BM) Iron Stain | |
| 333 | Bone Marrow (BM) Reporting | |
| 334 | Bone Marrow Failure Syndromes Panel - 39 genes | |
| 335 | Borjeson-Forssman-Lehmann syndrome (BFLS) | |
| 336 | Borrelia Burgdorferi IgM & IgG | |
| 337 | BP 180 (Bullous Pemphigoid 180 Vesiculobullous Disorders) | |
| 338 | BP 230 (Bullous Pemphigoid 230 Vesiculobullous Disorders) | |
| 339 | Brachydactyly, type C (BDC) | |
| 340 | Brachydacytly-mental retardation syndrome (BDMR) | |
| 341 | Branchio-otorenal Spectrum Disorders Panel - EYA1, SIX1, SALL1 | |
| 342 | Branchiootorenal syndrome 1 (BOR1) | |
| 343 | BRCA 1 & 2 Deletions/Duplications by MLPA | |
| 344 | BRCA1 AND BRCA 2 | |
| 345 | BRCA1 and BRCA2 BY MLPA | |
| 346 | Breast and Gynecological Cancers Panel - 35 genes | |
| 347 | Breast Cancer Panel - 26 genes | |
| 348 | Brucella Culture | |
| 349 | Brucella IgG | |
| 350 | Brucella IgM | |
| 351 | Brucellosis Titre | |
| 352 | Brugada Syndrome Panel - 20 genes | |
| 353 | BTP (Beta Trace Protein) Test | |
| 354 | BUN | |
| 355 | Bun/Creatinine Ratio | |
| 356 | Buschke-Ollendorff syndrome (BOS) | |
| 357 | C Diptheria | |
| 358 | C1 Esterase Inhibitor | |
| 359 | C1Q Complement | |
| 360 | C3 | |
| 361 | C4 | |
| 362 | CA 125 | |
| 363 | CA 125 Fluid | |
| 364 | CA 15-3 | |
| 365 | CA 19-9 | |
| 366 | CA 19-9 Fluid | |
| 367 | CA 72.4 | |
| 368 | Cadmium | |
| 369 | CADMIUM Level | |
| 370 | Calcitonin | |
| 371 | Calcium | |
| 372 | Calcium 24 Hour Urine | |
| 373 | Calcium Creatinine Ratio Urine | |
| 374 | Calcium Urine (Random) | |
| 375 | Calprotectin Stool | |
| 376 | CALR mutation detection | |
| 377 | Campomelic dysplasia (CMPD) | |
| 378 | Campomelic Dysplasia Test - SOX9 | |
| 379 | CANASSIST BREAST | |
| 380 | Canavan Disease Test - ASPA | |
| 381 | Cancer Karyotyping | |
| 382 | Candida Sensitivity Manual | |
| 383 | Capillary Malformation- Arteriovenous Malformation Syndrome Test - RASA1 | |
| 384 | Carbamezapine | |
| 385 | CARBA-R | |
| 386 | Cardio-Facio-Cutaneous Syndrome Panel- BRAF, KRAS, MAP2K1, MAP2K2, SHOC2, SOS1 | |
| 387 | Cardiomyopathy and Skeletal Muscle Disease Panel (upto 158 genes) | |
| 388 | Cardiomyopathy panel | |
| 389 | Cardiomyopathy, dilated, 1J (CMD1J) | |
| 390 | Carney Complex Test - PRKAR1A | |
| 391 | Carpenter Syndrome Panel -MEGF8, RAB23 | |
| 392 | CASR-Related Conditions Test | |
| 393 | Cat eye syndrome (CES) ( genetic study) | |
| 394 | Cat eye syndrome (CES) (FISH) | |
| 395 | Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Panel -ANK2, CALM1, CALM2, CALM3, CASQ2, KCNJ2, RYR2, TRDN | |
| 396 | Catecholamines | |
| 397 | Catecholamines 24 Hour Urine | |
| 398 | CBC | |
| 399 | CBC - ESR | |
| 400 | CBC-PS | |
| 401 | CD 19 Count | |
| 402 | CD 20 Count | |
| 403 | CD 25 | |
| 404 | CD3 Count | |
| 405 | CD3 Count For DLI(Donor Lymphocyte Infusion) | |
| 406 | CD3+CD4+CD8 ABSOLUTE COUNTS PROFILE | |
| 407 | CD34 Count | |
| 408 | CD4 CD8 Count | |
| 409 | CD4 Count | |
| 410 | CD5 Count | |
| 411 | CDC73-Related Conditions Test - CDC73 | |
| 412 | CEA | |
| 413 | CEA Body Fluid | |
| 414 | CEBPA | |
| 415 | Cell Free DNA - EGFR (DEL19+T790M+L858R) By DD PCR | |
| 416 | Central Core Disease Test - RYR1 | |
| 417 | Centromere Antibody | |
| 418 | Centronuclear Myopathy Panel - BIN1, CCDC78, DNM2, MTM1, R YR1, TTN, MYF6 | |
| 419 | Cerebral Cavernous Malformations Panel | |
| 420 | Cerebral Creatine Deficiency Panel - GAMT, GATM, SLC6A8 | |
| 421 | Cerebral creatine deficiency syndrome 1(CCDS1) | |
| 422 | Ceruloplasmin | |
| 423 | CFU LEVEL | |
| 424 | CH 50 (total hemolytic complement) | |
| 425 | Charcot-Marie-Tooth Disease Autosomal Dominant Panel - 20 genes | |
| 426 | Charcot-Marie-Tooth Disease Autosomal Recessive Panel - 14 genes | |
| 427 | Charcot-Marie-Tooth Disease Comprehensive Panel - 32 genes | |
| 428 | Charcot-Marie-Tooth Disease X- linked Panel- AIFM1, GJB1, PDK3, PRPS1 | |
| 429 | Charcot-Marie-Tooth disease type 1A (CMT1A ) | |
| 430 | CHARGE syndrome | |
| 431 | CHIKUNGUNIA IgG | |
| 432 | Chikungunia IgM (Rapid) | |
| 433 | Chikungunya PCR | |
| 434 | Chikungunya-Dengue combo | |
| 435 | Chlamydia IgG | |
| 436 | Chlamydia IgG & IgM | |
| 437 | Chlamydia IgM | |
| 438 | Chloride | |
| 439 | Chloride 24 Hour Urine | |
| 440 | Cholesterol | |
| 441 | Cholesterol Fluid | |
| 442 | Cholinesterase plasma/serum | |
| 443 | Cholinesterase RBC | |
| 444 | Chondrodysplasia punctata 1, X- linked recessive (CDPX1) | |
| 445 | Chondrodysplasia, Grebe type | |
| 446 | Choroideremia (CHM) | |
| 447 | Chromium | |
| 448 | Chromogranin A | |
| 449 | Chromosomal Deletion/Microdeletion Detection Panel | |
| 450 | Chromosomal microarray | |
| 451 | Chromosome 17p deletion | |
| 452 | Chronic granulomatous disease, X-linked (CGD) | |
| 453 | Chronic Pancreatitis Panel - CASR, CFTR, CTRC, PRSS1, SPINK 1 | |
| 454 | Chylomicrons | |
| 455 | Ciliopathies Sensory Panel-39 genes | |
| 456 | CLADOSPORIUM HERBARUM - SPECIFIC IGG | |
| 457 | Cleft palate, isolated (CPI) | |
| 458 | Cleidocranial dysplasia (CCD) | |
| 459 | CLINICAL EXOME SEQUENCING TEST | |
| 460 | Clinical Exome sequencing (8400 genes) | |
| 461 | CLL FISH and Karyotyping Panel | |
| 462 | CLL FISH Panel | |
| 463 | CLL PANEL | |
| 464 | Clopidogrel Drug sensitivity (CYP2C19 mutations) | |
| 465 | Clostridium Difficile Antigen (GDH) | |
| 466 | CLOSTRIDIUM DIFFICILE TOXIN | |
| 467 | Clostridium Difficile Toxin & Antigen | |
| 468 | Clostridium difficile toxin detection by PCR-Genexpert | |
| 469 | Clot Retraction | |
| 470 | CLOZAPINE LEVEL | |
| 471 | CMPD REFLEX PANEL | |
| 472 | CMV IgG | |
| 473 | CMV IgM | |
| 474 | CMV-Qualitative PCR | |
| 475 | CMV-Quantitation | |
| 476 | Co2 | |
| 477 | Cobalt Blood | |
| 478 | Coenzyme Q10-Coq10 Serum | |
| 479 | Coffin-Lowry syndrome (CLS) | |
| 480 | Cold Agglutinin Titre | |
| 481 | Colorectal Cancer Panel - 23 genes | |
| 482 | Combined hereditary dementia and amyotrophic lateral sclerosis panel (upto 27 genes) | |
| 483 | Common Hereditary Cancers Panel (Breast, Gyn, GI) - 42 genes | |
| 484 | Complement 3 (C3) Level | |
| 485 | Complement 4 (C4) Level | |
| 486 | Complement, total (CH50) | |
| 487 | Comprehensive Autosomal dominant cerebellar Ataxia panel | |
| 488 | Comprehensive Hereditary Cancer Panel - 34 genes | |
| 489 | Comprehensive Lung cancer panel (171 genes) | |
| 490 | Comprehensive Muscular Dystrophy Panel - 49 genes | |
| 491 | Comprehensive Myopathy Panel-40 genes | |
| 492 | Comprehensive Neuromuscular disorders panel + SOD1 | |
| 493 | Comprehensive neuromuscular disorders panel (upto 121 genes) | |
| 494 | Comprehensive Neuropathies panel (upto 83 genes) | |
| 495 | Congenital Adrenal Hypoplasia (CAH) | |
| 496 | Congenital Fiber-Type Disproportion Panel- ACTA1, LMNA, MYH7, RYR1, SEPN1, TPM2, TPM3 | |
| 497 | Congenital Heart Disease including Laterality Defects Panel - 72 genes | |
| 498 | Congenital Muscular Dystrophy Panel - 26 genes | |
| 499 | Congenital Myasthenic Syndrome Panel - 17 genes | |
| 500 | Congenital Myopathy Panel - 24 genes | |
| 501 | Constitutional Mismatch Repair- Deficiency Panel - EPCAM, MLH1, MSH2, MSH6, PMS2 | |
| 502 | Copper Level - Serum | |
| 503 | Cornelia de Lange syndrome 1 (CDLS1) | |
| 504 | Cornelia de Lange syndrome 2 (CDLS2) | |
| 505 | Cornelia de Lange Syndrome Panel - HDAC8, NIPBL, RAD21, SMC1A,SMC3 | |
| 506 | Coronary Heart Disease Risk Factor - 9p21 | |
| 507 | Cortical dysplasia-focal epilepsy syndrome | |
| 508 | Cortisol (4 PM) | |
| 509 | Cortisol (8 AM) | |
| 510 | Cortisol (Random) | |
| 511 | Cortisol Stimulation By ACTH | |
| 512 | Costello Syndrome - HRAS | |
| 513 | COVID-19 IgG Ab (SARS-CoV-2 IgG ) | |
| 514 | COVID-19 Ab TOTAL (SARS-CoV-2 Total . | |
| 515 | Cowden syndrome 1 (CWS1) | |
| 516 | C-Peptide (Post Prandial) | |
| 517 | C-Peptide (Fasting) | |
| 518 | C-Peptide (Random) | |
| 519 | CPK-MB | |
| 520 | CPK-MB BY CLIA/CMIA | |
| 521 | CPK-MM | |
| 522 | CPK-Total | |
| 523 | Craniofacial dysostosis with short stature | |
| 524 | Craniofrontonasal syndrome (CFNS) | |
| 525 | Craniosynostosis Panel-11 genes | |
| 526 | Craniosynostosis, type 2 (CRS2) | |
| 527 | CRC (COLORECTAL) TARGATED GENE PANEL | |
| 528 | Creatinine | |
| 529 | CREATININE Fluid | |
| 530 | Creatinine With EGFR | |
| 531 | Cri-du-Chat syndrome | |
| 532 | CRP (C - Reactive Protein) | |
| 533 | CRP-HS | |
| 534 | Cryoglobulin | |
| 535 | Cryptococcal Antigen- CSF | |
| 536 | Cryptococcal Antigen-Serum | |
| 537 | Culture and Sensitivity S Anaerobic | |
| 538 | Culture and Sensitivity ASCITIC FLUID | |
| 539 | Culture and Sensitivity BAL Fluid | |
| 540 | Culture and Sensitivity BLOOD AEROBIC AND ANAEROBIC BY Bactalert/Bactec | |
| 541 | Culture and Sensitivity Blood Aerobic By Bactalert/Bactec | |
| 542 | Culture and Sensitivity Blood Anaerobic By Bactalert/Bactec | |
| 543 | Culture and Sensitivity Blood By Conventional Method | |
| 544 | Culture and Sensitivity BLOOD FUNGAL BY Bactalert/Bactec | |
| 545 | Culture and Sensitivity Body Fluid | |
| 546 | Culture and Sensitivity Body Fluid Anaerobic By Bactalert/Bactec | |
| 547 | Culture and Sensitivity Body Fluid By Bactalert/Bactec | |
| 548 | Culture and Sensitivity Bone | |
| 549 | Culture and Sensitivity Bone Marrow By Bactalert/Bactec | |
| 550 | Culture and Sensitivity Bone Marrow Fungal By Bactalert/Bactec | |
| 551 | Culture and Sensitivity By Bactalert/Bactec | |
| 552 | Culture and Sensitivity Catheter Tip | |
| 553 | Culture and Sensitivity CSF | |
| 554 | Culture and Sensitivity CSF By Bactalert/Bactec | |
| 555 | Culture and Sensitivity CVP TIP | |
| 556 | Culture and Sensitivity Ear Swab | |
| 557 | Culture and Sensitivity ET | |
| 558 | Culture and Sensitivity Eye Swab | |
| 559 | Culture and Sensitivity Gonorrhea | |
| 560 | Culture and Sensitivity INTRALIPID | |
| 561 | Culture and Sensitivity MOTT | |
| 562 | Culture and Sensitivity ORAL SECRETION | |
| 563 | Culture and Sensitivity PANCREATIC FLUID | |
| 564 | Culture and Sensitivity Pericardial Fluid | |
| 565 | Culture and Sensitivity PERICARDIAL FLUID AUTOMATED SYSTEM WITH MIC SENSITIVITY | |
| 566 | Culture and Sensitivity Pericardial Fluid Bactalert/Bactec | |
| 567 | Culture and Sensitivity PERITONEAL (ASCITIC) FLUID | |
| 568 | Culture and Sensitivity Peritoneal Fluid By Bactalert/Bactec | |
| 569 | Culture and Sensitivity Pleural Fluid | |
| 570 | Culture and Sensitivity Pleural Fluid By Bactalert/Bactec | |
| 571 | Culture and Sensitivity PUS | |
| 572 | Culture and Sensitivity PUS Anaerobic | |
| 573 | Culture and Sensitivity -RT SECRETION | |
| 574 | Culture and Sensitivity Semen | |
| 575 | Culture and Sensitivity Sputum | |
| 576 | Culture and Sensitivity Stool | |
| 577 | Culture and Sensitivity Swab | |
| 578 | Culture and Sensitivity Synovial Fluid | |
| 579 | Culture and Sensitivity Synovial Fluid By Bactalert/Bactec | |
| 580 | Culture and Sensitivity Throat Swab | |
| 581 | Culture and Sensitivity Tissue | |
| 582 | Culture and Sensitivity Tissue Anaerobic | |
| 583 | Culture and Sensitivity Urine | |
| 584 | Culture and Sensitivity Vaginal Swab | |
| 585 | Culture and Sensitivity Wound | |
| 586 | CSF - Cerebro Spinal Fluid Analysis | |
| 587 | CSF - Glucose | |
| 588 | CSF Protein | |
| 589 | CSF CHIKUNGUNYA PCR | |
| 590 | CSF Cytospin | |
| 591 | CSF FOR CYTOLOGY | |
| 592 | CSF For Measles IgG | |
| 593 | CSF For Measles IgM | |
| 594 | CSF IgG | |
| 595 | CSF IgG Index | |
| 596 | CSF Oligoclonal Band | |
| 597 | CSF Protein | |
| 598 | CSF Tpha | |
| 599 | CSF VARICELLA IGG | |
| 600 | Currarino syndrome | |
| 601 | Cyclosporine | |
| 602 | CYFRA 21.1 | |
| 603 | Cystatin C | |
| 604 | Cystic fibrosis - CFTR (32 mutations) | |
| 605 | Cystic fibrosis - CFTR (delta508 mutation); with maternal cell contamination analysis | |
| 606 | Cystic fibrosis - CFTR (delta508 mutation) | |
| 607 | Cystic fibrosis Test (Exonic regions) | |
| 608 | Cystic fibrosis-CFTR(32 mutations) with maternal cell contamination analysis | |
| 609 | Cysticercosis (Taenia Solium) Antibody IgG | |
| 610 | Cysticercus(Taenia Solium) IgG | |
| 611 | Cystinosis, Nephropathic (CTNS) | |
| 612 | CYSTINOSIS, NEPHROPATHIC (CTNS) by NGS | |
| 613 | Cytomegalovirus Avidity IgG | |
| 614 | D3-Hydroxybutyrate( Acetone) Serum | |
| 615 | Dandy-Walker syndrome (DWS) | |
| 616 | Danon disease | |
| 617 | DCT- Gel System | |
| 618 | D-Dimer | |
| 619 | Deafness, autosomal dominant 10 (DFNA10) | |
| 620 | DENGUE ANTIGEN AND ANTIBODY (Rapid) | |
| 621 | Dengue IgG (ELISA) | |
| 622 | Dengue IgM (ELISA) | |
| 623 | Dengue NS1 Antigen (ELISA) | |
| 624 | Dengue PCR | |
| 625 | Dengue Profile (ELISA) | |
| 626 | Desmoglein (DSG) 1 And 3Antibody | |
| 627 | Desmoglein I & Iii Antibody | |
| 628 | DETECTION OF PARAQUAT URINE | |
| 629 | DGP IgA (Deamidated gliadin peptide (DGP) antibodies (anti-DGP) | |
| 630 | DGP IgG (Deamidated gliadin peptide (DGP) antibodies (anti-DGP) | |
| 631 | DHEA | |
| 632 | DHEA-S | |
| 633 | DHR (Dihydrorhodamine) Assay | |
| 634 | Diabetes Mellitus Autoantibody Panel Type -1 | |
| 635 | Diamond-Blackfan Anemia Panel-10 genes | |
| 636 | DICER1 Syndrome Test | |
| 637 | DiGeorge syndrome (DGS) | |
| 638 | DiGeorge syndrome/velocardiofacial syndrome complex-2 | |
| 639 | Digoxin | |
| 640 | Dihydropyrimidine dehydrogenase deficiency | |
| 641 | Dihydrotestosterone (DHT) | |
| 642 | Dilated cardiomyopathy panel | |
| 643 | DIPHTHERIA-PERTUSSIS-TETANUS ANTIBODY PANEL IgG | |
| 644 | Disorders of Male Sex Development Panel - NR0B1, NR5A1, SRY, AR,SRD5A2 | |
| 645 | Distal Myopathy Panel - 17 genes | |
| 646 | DMD (26 exons) | |
| 647 | DMD (79 exons) | |
| 648 | DNA Fragmentation Index/NCD | |
| 649 | DNA Isolation | |
| 650 | DNA Profiling | |
| 651 | Donor of LYMPHOCYTE CROSS MATCH REPORT (CDC) | |
| 652 | Donor of T & B CELL FLOW CROSS MATCH (FCXM) REPORT | |
| 653 | DONOR SPECIFIC ANTIBODY (DSA) | |
| 654 | DONOR SPECIFIC ANTIBODY (DSA) by LUMINEX | |
| 655 | Double Marker | |
| 656 | Down syndrome | |
| 657 | Drug susceptibility by disk diffusion | |
| 658 | Duane-radial ray syndrome (DRRS) | |
| 659 | Duane-Radial Ray Syndrome Test - SALL4 | |
| 660 | Dyggve-Melchior-Clausen disease (DMC) | |
| 661 | Dyskeratosis Congenita Panel- CTC1, DKC1, NHP2, NOP10, TER C, TERT, TINF2 | |
| 662 | Dystonia Comprehensive Panel -18 genes | |
| 663 | Dystroglycanopathy Panel -17 genes | |
| 664 | Dystrophinopathies Test - DMD | |
| 665 | E2A | |
| 666 | Early Infantile Epileptic Encephalopathy Panel - 43 genes | |
| 667 | EBV EA IgG | |
| 668 | EBV EA IgM | |
| 669 | EBV EBNA IgG | |
| 670 | EBV Panel | |
| 671 | EBV Qualitative PCR | |
| 672 | EBV Quantitative PCR | |
| 673 | EBV VCA IgG | |
| 674 | EBV VCA IgM | |
| 675 | Echinococcus (Hydatid Cyst) IgG | |
| 676 | Ectodermal Dysplasia Panel- EDA, EDAR, EDARADD, WNT10A | |
| 677 | Edwards syndrome | |
| 678 | eGFR | |
| 679 | EGFR (lung cancer NSCLC) | |
| 680 | EGFR Mutation analysis | |
| 681 | Ehlers-danlos Syndrome (vascular) - COL3A1 (targeted) | |
| 682 | ELANE-Related Neutropenia Test | |
| 683 | Electrolyte 24 Hour Urine | |
| 684 | Electrolytes | |
| 685 | Electrolytes Extended with Anion Gap | |
| 686 | Electrolytes Urine | |
| 687 | ELECTRON MICROSCOPY | |
| 688 | ELT(Euglobulin Lysis Time) | |
| 689 | EMA binding test for Hereditary Spherocytosis | |
| 690 | Emery-Dreifuss Muscular Dystrophy Panel- EMD, FHL1, LMNA, SYNE1,TMEM43 | |
| 691 | ENA PROFILE QUALITATIVE ELISA (extractable nuclear antigens (ENA) | |
| 692 | ENA PROFILE QUANTITATIVE BY ELISA | |
| 693 | Endomycial Antibody IgA | |
| 694 | Endomycial Antibody IgG | |
| 695 | Endomysial Antibody | |
| 696 | Endotoxin Water | |
| 697 | EOSINOPHILIC LEUKEMIA PANEL(PDGFRA,PDGFRB,FGFR1 AND CBFB) | |
| 698 | Epilepsy Panel - 103 genes | |
| 699 | EPO (Erythyropoetion) | |
| 700 | ESR 1 Hour | |
| 701 | ESR 2 Hour | |
| 702 | Estradiol (E2) | |
| 703 | Estriol (E3 Level) | |
| 704 | Estriol Uncongugated (E3 Level) | |
| 705 | Everolimus Level | |
| 706 | Examination For Pneumocystis Carinii | |
| 707 | EXFOLIATIVE CYTOLOGY | |
| 708 | ExoSAP-06 (Enzymatic Purification) | |
| 709 | Fabry disease | |
| 710 | Fabry Disease Test by NGS | |
| 711 | Factor II Assay | |
| 712 | Factor II mutation by PCR | |
| 713 | Factor II mutation by Sanger | |
| 714 | Factor IX Assay | |
| 715 | Factor V Assay | |
| 716 | Factor V Leiden Mutation by PCR | |
| 717 | Factor V Leiden Mutation by Sanger | |
| 718 | Factor VII Assay | |
| 719 | Factor VIII Assay | |
| 720 | Factor X Assay | |
| 721 | Factor XI Assay | |
| 722 | Factor XII Assay | |
| 723 | Familial Acute Myeloid Leukemia with Mutated CEBPA Test - CEBPA | |
| 724 | Familial adenomatous polyposis 1 (FAP1) | |
| 725 | Familial Adenomatous Polyposis - APC | |
| 726 | Familial Cutaneous Melanoma - CDK4, CDKN2A | |
| 727 | Familial Dysautonomia Test | |
| 728 | Familial Dysautonomia Test - IKBKAP | |
| 729 | Familial Gastrointestinal Stromal Tumor Syndrome Panel- KIT, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD | |
| 730 | Familial Hypercholesterolemia - APOB, LDLR, LDLRAP1, PCSK9 | |
| 731 | Familial Neuroblastoma Panel- ALK, PHOX2B, KIF1B | |
| 732 | Familial Thrombocytopenia with propensity to Acute Myelogenous Leukemia- RUNX1 | |
| 733 | Fanconi Anemia Panel - 17 genes | |
| 734 | Fasting Blood Sugar (FBS) | |
| 735 | FASTING URINE SUGAR | |
| 736 | Fatty Acid Oxidation Defects Panel-17 genes | |
| 737 | FBG/F INSULIN RATIO | |
| 738 | FDP | |
| 739 | FECAL ELASTASE | |
| 740 | Feingold syndrome 1 (FGLDS1) | |
| 741 | Ferritin | |
| 742 | FGFR3-Related Disorders Test | |
| 743 | Fibrinogen | |
| 744 | Fibrinogen degradation Product (FDP) | |
| 745 | FIBROBLAST GROWTH FACTOR 23 | |
| 746 | Filaria Antigen | |
| 747 | FIP1L1-PDGFRA gene rearrangement | |
| 748 | FISH - CDKN2A/CEP 9 | |
| 749 | FISH - CEP 8 ( TRISOMY 8) | |
| 750 | FISH - DEL 17p on CD 138 Enriched Plasma Cells | |
| 751 | FISH - IGH gene rearrangement | |
| 752 | FISH PANEL FOR PH LIKE ALL | |
| 753 | FISH 1p/19q | |
| 754 | FISH ABL1 GENE REARRANGEMENT | |
| 755 | FISH ABL2 GENE REARRANGEMENT | |
| 756 | FISH ABORTUS MATERIAL (13 18 21 X & Y) | |
| 757 | FISH ALK GENE REARRAGNGEMENT | |
| 758 | FISH AML/ETO t(8;21) | |
| 759 | FISH BCL1 /IGH T(11;14) (Mantle Cell Lymphoma) - Paraffin Block | |
| 760 | FISH BCL1/IGH t(11;14) (MANTLE CELL LYMPHOMA) Bone Marrow | |
| 761 | FISH BCL2 GENE REARRANGEMENT Bone Marrow | |
| 762 | FISH BCL2 Gene Rearrangement Paraffin Block | |
| 763 | FISH BCL6 GENE REARRANGEMENT Bone Marrow | |
| 764 | FISH BCL6 Gene Rearrangement Paraffin block | |
| 765 | FISH BCR/ABL t(9;22) | |
| 766 | FISH C MYC Gene Rearrangement Paraffin Block | |
| 767 | FISH C MYC GENE REARRANGEMENT Bone Marrow | |
| 768 | FISH CEP XY (CHIMERISM) | |
| 769 | FISH CRLF2 GENE REARRANGEMENT | |
| 770 | FISH DEL 13q | |
| 771 | FISH DEL 15q11/15q24 (Prader willi syndrome) | |
| 772 | FISH Del 17p / Del 11q | |
| 773 | FISH del 1p32.2(CDKN2C)/ amp 1q21.3-q22(CKS1B) | |
| 774 | FISH DEL 20q | |
| 775 | FISH DEL 22q11/22q13 (DiGeorge syndrome) | |
| 776 | FISH DEL 5q | |
| 777 | FISH DEL 7q | |
| 778 | FISH FGFR1 GENE REARRANGEMENT | |
| 779 | FISH FGFR3/IGH t(4;14) | |
| 780 | FISH for BCL2::IGH gene rearrangement / t(14;18) | |
| 781 | FISH for CHROMOSOME 21 (trisomy 21) | |
| 782 | FISH for CHROMOSOME 13 18 & 21 | |
| 783 | FISH for CHROMOSOME 13 & 21 | |
| 784 | FISH for CHROMOSOME 18 & 21 | |
| 785 | FISH for HIGH GRADE LYMPHOMA PANEL( BCL2/BCL6/C MYC ) Paraffin Block | |
| 786 | FISH for HIGH GRADE LYMPHOMA PANEL( BCL2/BCL6/C MYC ) Bone marrow | |
| 787 | FISH FOR MYELOMA [Del 13q Del 11q Del 17p t(11:14) t(4;14) t(14;16) Del 1p/amp1q] | |
| 788 | FISH FOXO1 gene rearrangement | |
| 789 | FISH HER2 Neu | |
| 790 | FISH Inv(16) | |
| 791 | FISH JAK2 GENE REARRANGEMENT | |
| 792 | FISH MAF/IGH t(14;16) | |
| 793 | FISH MET GENE AMPLIFICATION | |
| 794 | FISH MLL gene rearrangement | |
| 795 | FISH MYE0V/IGH t(11;14) | |
| 796 | FISH N MYC GENE AMPLIFICATION | |
| 797 | FISH ON CD 138 ENRICHED PLASMA CELL FOR MULTIPLE MYELOMA | |
| 798 | FISH PDGFR ALPHA | |
| 799 | FISH PDGFR BETA | |
| 800 | FISH PML/RARA t(15;17) | |
| 801 | FISH RET GENE REARRANGEMENT | |
| 802 | FISH ROS1 GENE REARRANGEMENT | |
| 803 | FISH SEMEN (13 18 21 X & Y) | |
| 804 | FISH SYNOVIAL SARCOMA (SS-18 GENE) | |
| 805 | FISH t(1;19) E2A/PBX1 | |
| 806 | FISH TEL/AML t(12;21) | |
| 807 | FISH Trisomy 12 | |
| 808 | FISH-EWINGS SARCOMA (EWSR1 GENE REARRANGEMENT) | |
| 809 | FLT3 mutation | |
| 810 | Flu/H1N1 2009 | |
| 811 | Fluid Albumin | |
| 812 | Fluid Amylase | |
| 813 | Fluid Bile Salt And Bile Pigment | |
| 814 | Fluid CEA | |
| 815 | Fluid Cell Count | |
| 816 | FLUID CHLORIDE | |
| 817 | Fluid Creatinine | |
| 818 | Fluid For AFB | |
| 819 | FLUID FOR CYTOLOGY | |
| 820 | FLUID FOR CYTOLOGY WITH CELL BLOCK | |
| 821 | Fluid For Protein | |
| 822 | Fluid Gram And Z N Stain | |
| 823 | Fluid LDH | |
| 824 | Fluid Lipase | |
| 825 | Fluid Routine Examination | |
| 826 | Fluid- Sugar | |
| 827 | FNAC - (Prepared 6 Slides) | |
| 828 | FNAC SLIDES FOR REVIEW (13 - 18 SLIDES) | |
| 829 | FNAC SLIDES FOR REVIEW (19 - 24 SLIDES) | |
| 830 | FNAC SLIDES FOR REVIEW (25 - 30 SLIDES) | |
| 831 | FNAC SLIDES FOR REVIEW (31 SLIDES) | |
| 832 | FNAC SLIDES FOR REVIEW (6 - 12 SLIDES) | |
| 833 | FNAC SLIDES FOR REVIEW (UP TO 6 SLIDES) | |
| 834 | Focal dermal hypoplasia (FDH) | |
| 835 | Folate (Folic Acid) RBC | |
| 836 | Folic Acid | |
| 837 | FOOD INTOLERANCE PROFILE | |
| 838 | Forebrain defects | |
| 839 | Foundation One CDx (F1Cdx) | |
| 840 | Foundation One HEME | |
| 841 | Foundation One Liquid CDx (F1LCdx) | |
| 842 | Fractional Excretion of Sodium (FENa) | |
| 843 | Fragile X - Female | |
| 844 | Fragile X - Male | |
| 845 | Fragile X (repeat expansion analysis) - FMR1 | |
| 846 | Fragile X mental retardation syndrome | |
| 847 | Free Androgen Index | |
| 848 | Free Beta HCG | |
| 849 | Free Cortisol - 24 Hrs Urine | |
| 850 | Free Hemoglobin (Plasma Hemoglobin) | |
| 851 | Free Kappa Light Chain | |
| 852 | Free Lambda Light Chain | |
| 853 | Free Light Chain Assay | |
| 854 | Free Protein S | |
| 855 | Free PSA | |
| 856 | Free Testosterone | |
| 857 | Friedreich Ataxia Mutation Analysis | |
| 858 | Frontotemporal dementia panel (upto 13 genes) | |
| 859 | Frozen Section (Intra Operative) | |
| 860 | Fructosamine | |
| 861 | FSH | |
| 862 | FT3 (Free T3) | |
| 863 | FT4 (Free T4) | |
| 864 | FUNGAL CULTURE | |
| 865 | Fungal MIC by broth dilution | |
| 866 | FUNGUS IDENTIFICATION | |
| 867 | FUNGUS IDENTIFICATION AND SENSITIVITY | |
| 868 | FUNGUS SENSITIVITY | |
| 869 | G6PD Qualitative | |
| 870 | G6PD Quantitative | |
| 871 | GAD 65 Antibody (for Paraneoplastic syndrome) | |
| 872 | GALACTOSEMIA QUANTITATIVE | |
| 873 | Galactosemia Panel- GALE, GALK1, GALT | |
| 874 | Ganglioside Antibody IgG and IgM | |
| 875 | Gastric Cancer Panel - 19 genes | |
| 876 | Gastric Juice For Hemosiderophage | |
| 877 | Gastrin Level | |
| 878 | GATA1-Related X-Linked Cytopenia Test | |
| 879 | GATA2 Deficiency Test | |
| 880 | GelEx-07 (Gel Extraction) | |
| 881 | GeneSynthesis-1 (436 base pair-1 kb) | |
| 882 | GeneSynthesis-10 (6-10 kb) | |
| 883 | GeneSynthesis-2 (1-2 kb) | |
| 884 | GeneSynthesis-3 (2-3 kb) | |
| 885 | GeneSynthesis-4 (3-4 kb) | |
| 886 | GeneSynthesis-6 (4-6 kb) | |
| 887 | Germline Cancer Panel | |
| 888 | GGT | |
| 889 | GH (Growth Hormone) | |
| 890 | GH STIMULATION TEST | |
| 891 | GIARDIA Ag Stool | |
| 892 | Giemsa Stain | |
| 893 | Gilbert syndrome | |
| 894 | GLI3-Related Disorders Test | |
| 895 | GLIADIN IGA | |
| 896 | Gliadin IgG | |
| 897 | Gliadin IgG & IgA Profile | |
| 898 | Glioma Comprehensive Panel | |
| 899 | Glioma Extended Diagnostic & Prognostic Panel | |
| 900 | Glioma Molecular Panel | |
| 901 | Glucose Fluid | |
| 902 | Glucose Transporter Type 1 Deficiency Syndrome Test- SLC2A1 | |
| 903 | Glucose-6-Phosphate Dehydrogenase Deficiency Test- G6PD | |
| 904 | Glutaric Acidemia Type I Test - GCDH | |
| 905 | Glycerol kinase deficiency | |
| 906 | Gms Stain | |
| 907 | Gonorrhoea - Microscopy | |
| 908 | Gram Stain | |
| 909 | Greig cephalopolysyndactyly syndrome (GCPS) | |
| 910 | H. Pylori Ag Stool | |
| 911 | H. Pylori IgA | |
| 912 | H. Pylori IgG | |
| 913 | H.Pylori IgM | |
| 914 | HAM TEST | |
| 915 | Hanging Drop Preparation | |
| 916 | Hanta Virus IgM-Antibodies | |
| 917 | Haptoglobin | |
| 918 | HAV Antibody IgM (Rapid) | |
| 919 | HAV IgM | |
| 920 | HAV-IgG | |
| 921 | HB Electrophoresis - HPLC | |
| 922 | Hb electrophoresis by Capillary | |
| 923 | Hb H Preparation | |
| 924 | HBA1c (Glycosylated Hemoglobin) | |
| 925 | HbA1C by Turbidimetry | |
| 926 | HbA1C (HPLC) | |
| 927 | HbeAg | |
| 928 | HBsAg by ELFA | |
| 929 | HBsAg CMIA | |
| 930 | HBsAg ELISA | |
| 931 | HbsAg rapid | |
| 932 | Hbsag-Quantitative (End Point Titre) | |
| 933 | HBV by Taqman | |
| 934 | HBV drug resistance (HBV Quantitative values mandatory) | |
| 935 | HBV Genotyping (HBV Quantitative values mandatory) | |
| 936 | HBV genotyping and drug resistance mutations (HBV Quantitative values mandatory) | |
| 937 | HBV-Qualitative PCR | |
| 938 | HBV-Quantitation | |
| 939 | HCO3 (Bicarbonate) | |
| 940 | HCV Genotyping (HCV Quantitative values mandatory) | |
| 941 | HCV IgM | |
| 942 | HCV Quantitative and Genotyping | |
| 943 | HCV RNA-Quantitation | |
| 944 | HCV-Qualitative PCR | |
| 945 | HDL Cholesterol | |
| 946 | HDV (Hepatitis delta virus) QUALITATIVE | |
| 947 | HDV IgM | |
| 948 | HE4 ROMA INDEX | |
| 949 | HE4 -Roma Index Human Epididymis Protein-4 Serum | |
| 950 | HE4 With ROMA Index | |
| 951 | HEAVY METALS (NINE PANEL) | |
| 952 | Heinz Bodies | |
| 953 | Hematocrit-Fluid | |
| 954 | Hemochromatosis (Targeted) - HFE | |
| 955 | Hemophilia (A&B) And Von Will Brad Disease Workup | |
| 956 | Hemophilia A (HEMA) | |
| 957 | Hemophilia B (HEMB) | |
| 958 | Hemophilia complete workup (F8 & F9 gene sequencing + F8 intron 22 & 1 inversion) | |
| 959 | Heparin Induced Thrombocytopenia (HIT Testing) | |
| 960 | Hepatitic C Virus (HCV) - Rapid | |
| 961 | HEPATITIS B VIRUS (HBV) GENOTYPES & DRUG RESISTANCE | |
| 962 | HEPATITIS D VIRUS ( HDV) ANTIBODY- TOTAL | |
| 963 | Hepcidin Level | |
| 964 | HER2 (ERBB2) (Equivocal) by FISH | |
| 965 | Her-2 Neu (H2N) | |
| 966 | Hereditary Alzheimers disease panel (3 genes) | |
| 967 | Hereditary Breast Cancer (high risk panel) - BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, TP53 | |
| 968 | Hereditary Breast Cancer (extended panel)- 17 genes | |
| 969 | Hereditary Breast Cancer (moderate risk panel) - 10 genes | |
| 970 | Hereditary Cancer Risk Assessment - 30 genes | |
| 971 | Hereditary Colon Cancer - 14 genes | |
| 972 | Hereditary Diffuse Gastric Cancer Syndrome- CDH1 | |
| 973 | Hereditary Fructose Intolerance- ALDB | |
| 974 | Hereditary Gynecologic Cancers (high risk panel)- BRCA1, BRCA2, EPCAM, MLH1, MSH2, MSH6, PMS2, PTEN, TP53 | |
| 975 | Hereditary Hemochromatosis Panel - HAMP, HFE, HFE2, SLC40A1, TFR2 | |
| 976 | Hereditary Hemorrhagic Telangiectasia Panel - ACVRL1, ENG, RASA1, SMAD4, GDF2 | |
| 977 | Hereditary Hyperparathyroidism Panel- CASR, CDC73, CDKN1B, MEN1,RET | |
| 978 | Hereditary Leiomyomatosis and Renal Cell Cancer Test - FH | |
| 979 | Hereditary motor neuropathy panel | |
| 980 | Hereditary Papillary Renal Cell Cancer - MET | |
| 981 | Hereditary Paraganglioma- Pheochromocytoma Panel - 14 genes | |
| 982 | Hereditary Parkinsons disease and Parkinsonism panel (upto 17 genes) | |
| 983 | Hereditary Prion disease test | |
| 984 | Hereditary Sensory and Autonomic Neuropathy panel (upto 17 genes) | |
| 985 | Hereditary Spastic Paraplegia Autosomal Dominant Panel - 12 genes | |
| 986 | Hereditary Spastic Paraplegia Autosomal Recessive Panel - 27 genes | |
| 987 | Hereditary Spastic Paraplegia X- linked Panel- KDM5C, L1CAM, PLP1, SLC16A2 | |
| 988 | Hereditary Spastic Paraplegia Comprehensive Panel - 43 genes | |
| 989 | Hereditary Thrombophilia Panel- F2, F5, PROC, PROS1, SERPINC1, F9, MPL | |
| 990 | Herpes Zoster - IgG | |
| 991 | Herpes Zoster - IgG & IgM | |
| 992 | Herpes Zoster - Igm | |
| 993 | Heterotaxy - CCDC39, CCDC40, FOXH1, GDF1, NODAL, ZIC3 | |
| 994 | Heterotaxy, visceral, 1, X-linked (HTX1) | |
| 995 | HEV Antibody IgM (Rapid) | |
| 996 | HEV- IgG | |
| 997 | HEV-IgM | |
| 998 | Hexosaminidase 1 level | |
| 999 | Hirschsprung disease, susceptibility to, 1 (HSCR1) | |
| 1000 | Hirschsprung disease, susceptibility to, 2 (HSCR2) | |
| 1001 | HISTO PATHOLOGICAL EXAMINATION OF RENAL BIOPSY ALLOGRAFT + C4D (WITHOUT IF) | |
| 1002 | HISTO STAIN - ANY SPECIAL STAIN | |
| 1003 | HISTO STAIN - CONGO - THIO T | |
| 1004 | HISTO STAIN - THIO-T | |
| 1005 | HISTOPATHOLOGICAL EXAMINATION OF KIDNEY BIOPSY WITH SPECIAL STAINS & IMMUNOFLUORESCENCE | |
| 1006 | HISTOPATHOLOGICAL EXAMINATION OF NERVE WITH SPECIAL STAINS | |
| 1007 | HISTOPATHOLOGICAL EXAMINATION OF SKIN WITH IMMUNOFLUROSCENCE | |
| 1008 | HISTOPATHOLOGY SLIDE-1 | |
| 1009 | HISTOPATHOLOGY SLIDE-10 | |
| 1010 | HISTOPATHOLOGY SLIDE-11 | |
| 1011 | HISTOPATHOLOGY SLIDE-2 | |
| 1012 | HISTOPATHOLOGY SLIDE-3 | |
| 1013 | HISTOPATHOLOGY SLIDE-4 | |
| 1014 | HISTOPATHOLOGY SLIDE-5 | |
| 1015 | HISTOPATHOLOGY SLIDE-6 | |
| 1016 | HISTOPATHOLOGY SLIDE-7 | |
| 1017 | HISTOPATHOLOGY SLIDE-8 | |
| 1018 | HISTOPATHOLOGY SLIDE-9 | |
| 1019 | HIV BY RAPID | |
| 1020 | HIV & HBsAg by CMIA | |
| 1021 | HIV Duo (ELFA) | |
| 1022 | HIV Genotyping and drug resistance mutations | |
| 1023 | HIV I & II - Rapid | |
| 1024 | HIV I & II by CMIA | |
| 1025 | HIV I & II by eCLIA | |
| 1026 | HIV I & II ELISA | |
| 1027 | HIV PROVIRAL DNA LOAD PCR | |
| 1028 | HIV Western Blot | |
| 1029 | HIV-1 RNA -Quantitation | |
| 1030 | HIV-Qualitative PCR | |
| 1031 | HLA B27 | |
| 1032 | HLA B27 By Flowcytometry | |
| 1033 | HLA Typing + Cross Match | |
| 1034 | HOLO TC (HOLO B12)- Holotranscobalamin | |
| 1035 | Holoprosencephaly (HPE) Panel | |
| 1036 | Holoprosencephaly Panel - GLI2, SHH, SIX3, TGIF1, ZIC2 | |
| 1037 | Holt-Oram syndrome (HOS) | |
| 1038 | Holt-Oram Syndrome Test - TBX5 | |
| 1039 | Homa Index Insulin Resistance Test | |
| 1040 | Homa IR Insulin Resistance Index | |
| 1041 | Homocysteine Serum | |
| 1042 | HOMOCYSTEINE URINE | |
| 1043 | Homocystinuria Panel - CBS, MMACHC, MMADHC, MTRR | |
| 1044 | HPV High risk Typing | |
| 1045 | HPV Qualitative 16/18 typing | |
| 1046 | HS -CRP | |
| 1047 | HSV I & II IgG | |
| 1048 | HSV I & II IgM | |
| 1049 | HSV I IgG | |
| 1050 | HSV I IgG & IgM | |
| 1051 | HSV I IgM | |
| 1052 | HSV II IgG | |
| 1053 | HSV II IgG & IgM | |
| 1054 | HSV II IgM | |
| 1055 | HSV1 and HSV2-Qualitative | |
| 1056 | HSV1 and HSV2-Quantitation | |
| 1057 | HTLV I & II serum | |
| 1058 | Huntington disease | |
| 1059 | Hyperkalemic periodic paralysis panel | |
| 1060 | Hyperparathyroidism Panel- CASR, CDC73, CDKN1B, MEN1, RET | |
| 1061 | Hyperphenylalaninemia Panel - GCH1, PAH, PCBD1, PTS, QDPR | |
| 1062 | Hyperprolinemia Panel - ALDH4A1, PRODH | |
| 1063 | HYPERSENSITIVITY PNEUMONITIS PANEL SERUM | |
| 1064 | Hypertrophic Cardiomyopathy Panel | |
| 1065 | Hypoparathyroidism, sensorineural deafness and renal disease | |
| 1066 | Hypophosphatemic rickets, X-linked dominant (XLHR) | |
| 1067 | Hypotonia-cystinuria syndrome | |
| 1068 | IA2 INSULIN AUTOANTIBODIES CLIA | |
| 1069 | Ichthyosis, X-linked (XLI) | |
| 1070 | ICT (Indirect Coombs Test) - Gel System | |
| 1071 | ICT (INDIRECT COOMBS TEST)- Tube Agglutination | |
| 1072 | IDH mutations | |
| 1073 | IgA | |
| 1074 | IgD Heavy Chain (Surface) | |
| 1075 | IgE | |
| 1076 | IgF Bp-3 | |
| 1077 | IGF BP3 | |
| 1078 | IGF-1 | |
| 1079 | IgG | |
| 1080 | IgG Subclasses 1-4 | |
| 1081 | IgG1 | |
| 1082 | IgG2 | |
| 1083 | IgG3 | |
| 1084 | IgG4 | |
| 1085 | IGH rearrangement | |
| 1086 | IGH rearrangement t(11;14), t(4;14), t(14;16) | |
| 1087 | IgM | |
| 1088 | IgM rheumatoid factor | |
| 1089 | IgVH Gene mutation | |
| 1090 | IHC ANY SINGLE MARKER | |
| 1091 | IHC Any Single Marker With Reporting | |
| 1092 | IHC ANY THREE MARKERS | |
| 1093 | IHC ANY TWO MARKERS | |
| 1094 | IHC C4D (IHC/IF) | |
| 1095 | IHC ER PR | |
| 1096 | IHC ER PR HER2 NEU Ki67+REFLEX FISH HER2NEU | |
| 1097 | IHC ER PR HER2 NEU+REFLEX FISH HER2NEU | |
| 1098 | IHC ER PR HER2-NEU | |
| 1099 | IHC ER PR HER2-NEU Ki67 | |
| 1100 | IHC EXTENDED PANEL | |
| 1101 | IHC HER-2 NEU | |
| 1102 | IHC IN SITU HYBRIDIZATION (E-BER) | |
| 1103 | IHC MSI | |
| 1104 | IHC MSI (HO) | |
| 1105 | IHC PANEL | |
| 1106 | IHC Panels With Reporting Er Pr C-Erb-B2(Her2 Neu) - 720 | |
| 1107 | IHC PDL1 BY DAKO (22C3) | |
| 1108 | IHC ROS1(LUNG MARKER) | |
| 1109 | IHC STAINING | |
| 1110 | IHC up to 5 markers | |
| 1111 | Imatinib Resistance Mutation Analysis (IRMA) | |
| 1112 | Immature Platelet Fraction (IPF) | |
| 1113 | IMMUNOFIXATION ELECTROPHORESIS 24 hours urine | |
| 1114 | IMMUNOFIXATION ELECTROPHORESIS COMPLETE PANEL WITH B-2 MICR | |
| 1115 | Immunofixation Electrophoresis Qulalitative | |
| 1116 | IMMUNOFIXATION WITH PROTEIN ELECTROPHORESIS | |
| 1117 | Immunoglobulin Profile | |
| 1118 | IMMUNOPHENOTYPING - LEUKEMIA PANEL | |
| 1119 | IMMUNOPHENOTYPING - LYMPHOMA PANEL | |
| 1120 | Immunophenotyping EMA Dya Binding Test | |
| 1121 | Immunophenotyping For ALPS | |
| 1122 | Immunophenotyping For Leukocyte Adhesion Defect -I | |
| 1123 | Immunophenotyping For MRD | |
| 1124 | Immunophenotyping For T Cell Subset | |
| 1125 | Immunophenotyping For Myeloma | |
| 1126 | Immunophenotyping For Platelet Function Test | |
| 1127 | Immunophenotyping Leukemia Panel In Body Fluid | |
| 1128 | Immunophenotyping Leukemia Panel | |
| 1129 | Immunophenotyping Leukemia/Lymphoma(CLPD) | |
| 1130 | Inclusion body myopathy panel (upto 5 genes) | |
| 1131 | Incontinentia pigmenti (IP) | |
| 1132 | Indian Ink Examination For Cryptococcus Neoformans | |
| 1133 | Infectious Mononucleosis | |
| 1134 | Inflammatory Bowel Disease (IBD) Differentiation Panel | |
| 1135 | INFLUENZA A IGG | |
| 1136 | Influenza A IgG Antibody | |
| 1137 | INFLUENZA A IGM | |
| 1138 | Influenza B IgG Antibody | |
| 1139 | Inhibin A | |
| 1140 | Inhibin B | |
| 1141 | Inhibitor Assay Study | |
| 1142 | Inhibitors Screen | |
| 1143 | Insulin (Fasting) | |
| 1144 | Insulin (PP) | |
| 1145 | Insulin (Random) | |
| 1146 | Insulin 1 Hour After Glucose | |
| 1147 | Insulin 2 Hour After Glucose | |
| 1148 | Insulin Antibody | |
| 1149 | Interleukin 6 | |
| 1150 | Intrinsic Factor Antibody | |
| 1151 | inv (16) | |
| 1152 | Iodine Serum | |
| 1153 | Ionized Calcium | |
| 1154 | IPT - AML MRD(MRD- Measurable residual disease) | |
| 1155 | IPT - B ALL MRD | |
| 1156 | IPT - CLPD MRD( CLPD-Chronic Lymphoproliferative Disorders | |
| 1157 | IPT - LEUKEMIA PANEL / LYMPHOMA PANEL | |
| 1158 | IPT - Multiple Myeloma MRD | |
| 1159 | IPT - MYLOMA PANEL | |
| 1160 | IPT - T ALL MRD | |
| 1161 | IPT- ALPS PANEL | |
| 1162 | Iridogoniodysgenesis, type 1 (IRID1) | |
| 1163 | IRMA by NGS | |
| 1164 | Iron | |
| 1165 | Iron Profile | |
| 1166 | Iron Stain | |
| 1167 | ISLET CELL ANTIBODIES BY CLIA | |
| 1168 | ISLET CELL ANTIBODIES by IFA | |
| 1169 | Isolated & Syndromic Congenital Heart Disease Panel -55 genes | |
| 1170 | Isolated Gonadotropin- Releasing Hormone Deficiency Panel - ANOS1, CHD7, FGFR1 | |
| 1171 | Isoniazid by HPLC |
Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy
For Tender Information Services Visit : TenderDetail